News

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of tirzepatide, the active ingredient in Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro. Lilly claims ...
INDIANAPOLIS — Eli Lilly filed lawsuits against compounding ... spa who Lilly says is misleading patients by selling what PWL claims to be “authentic,” “FDA-approved” Mounjaro and Zepbound. The ...
Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy.
Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro ... Lilly argues these claims are turning people toward compounded drugs and away from its FDA-approved treatments.
Tirzepatide is the active ingredient in Lilly weight-loss drug Zepbound and the diabetes drug Mounjaro. Related Experimental Eli Lilly weight ... is over The suits claim the companies are ...
Eli Lilly is reducing the price of the highest doses of its popular drug Zepbound for folks who aren't using insurance.
Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant's weight loss drug Zepbound and its ... Lilly also claims some of the sites are selling ...